Senior Industry Advisor - Healthcare & Life Sciences

Healthcare M&A in Europe is won by advisors who understand the regulatory, commercial, and clinical dimensions of a business — not just the financials. After 20+ years in the sector, you do. ONEtoONE is a global network of 120+ independent M&A advisors in 55 countries.

Our Senior Industry Advisors in healthcare co-advise on transactions where sector credibility is the critical differentiator — from pharma and biotech to medtech, diagnostics, and healthcare services. What you get Competitive revenue share on mandates you originate or where your healthcare expertise drives the process Active deal flow across UK and European healthcare: pharma, medtech, biotech, digital health, healthcare services Institutional brand: operate as a Senior Advisor of a recognised global investment banking platform 200+ advisors in 55 countries — connecting healthcare companies with global strategic buyers, PE sponsors, and trade buyers Full execution support: analyst team, sector databases, CIMs, and pitch materials provided Who you are Former CEO, MD, CMO, or CFO of a UK or European healthcare, pharma, or medtech company — 20+ years in the sector Deep personal network within the UK and European healthcare executive, PE, and investor community Experience with acquisitions, divestments, licensing deals, or investor processes from the operator's side Currently independent, on advisory boards, or exploring a portfolio career The business owner in healthcare trusts advisors who have navigated the same regulatory and commercial environments. ONEtoONE Senior Industry Advisors are exactly that — backed by a global M&A platform. #J-18808-Ljbffr